Treatment with grass allergen peptides improves symptoms of grass pollen–induced allergic rhinoconjunctivitisAnne K. Ellis, Roderick P. Hafner, Lisa Steacy et al.|Journal of Allergy and Clinical Immunology|2017Cited by 62
Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasonsAnne K. Ellis, Roderick P. Hafner, Lisa Steacy et al.|Journal of Allergy and Clinical Immunology|2019Cited by 19
Persistent Treatment Effect with Grass Synthetic Peptide Immuno-Regulatory Epitopes in Grass Allergy Symptoms in an Environmental Exposure Unit Challenge after a Second Season of Natural Pollen ExposureAnne K. Ellis, Robyn E. O’Hehir, Charles W. Frankish et al.|Journal of Allergy and Clinical Immunology|2015Cited by 11
Treatment With Synthetic Peptide Immuno-Regulatory Epitopes Derived From Grass Allergens Leads To a Substantial Reduction In Grass Allergy Symptoms In The Environmental Exposure UnitAnne K. Ellis, Rod Hafner, Charles W. Frankish et al.|Journal of Allergy and Clinical Immunology|2014Cited by 9
The Nasal Allergen Challenge Protocol of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Validation in a Clinical Trial of Cat Synthetic Peptide Immunoregulatory Epitopes (Cat-SPIRE)Helen Neighbour, Anne K. Ellis, Pascal Hickey et al.|Journal of Allergy and Clinical Immunology|2015Cited by 3